![PSILOSYBIN PSYCHEDELICS RESEARCH DOSING DAY](https://www.cpr.org/cdn-cgi/image/width=3840,quality=75,format=auto/https://wp-cpr.s3.amazonaws.com/uploads/2024/05/240306-PSILOCYBIN-RESEARCH-UC-ANSCHUTZ-HV-0011.jpg)
When people with cancer are facing the prospect of death, anxiety can consume their precious days. A medical trial in Colorado aims to change that with a drug that was once forbidden. CPR's Andrew Kenney explores how researchers are reopening the door to psilocybin, and what it's meant for one young mom, in Colorado In Depth.